Article | April 20, 2020

CCI For Combination Products: Assembling The Package Integrity Profile For Autoinjectors

By Brandon Zurawlow, Principal Consultant at Containsure

Insulin pen 450x300

Due to their complexity, combination products, specifically autoinjection systems, present unique challenges in implementing a container closure integrity (CCI) testing strategy. This is further complicated by a pervasive, though diminishing, tendency for companies to consider CCI only at the final product-package lifecycle stage, an approach where combination products will highlight the pitfalls. This article seeks to discuss the unique challenges of CCIT on combination products, and how to overcome them using a modern, risk management approach to CCI in line with current guidance and regulation: development of a package integrity profile.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Med Device Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

PTI Packaging and Inspection Systems